Motley Fool
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
📊
AI Sentiment
Positive
6/10
Cytokinetics Incorporated News
Latest updates and market news for CYTK
4 news
Mar 19 - Mar 25, 2026
Page 1
Motley Fool
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
âž–
AI Sentiment
Neutral
4/10
Motley Fool
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Mizuho Raises Price Target on Cytokinetics to $100 From $84, Keeps Outperform Rating
📈
AI Sentiment
Highly Positive
8/10
Share this news page